Akebia Therapeutics to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

Akebia Therapeutics to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

<br /> Akebia Therapeutics to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference<br />

PR Newswire



CAMBRIDGE, Mass.


,


Sept. 1, 2022


/PRNewswire/ —

Akebia Therapeutics, Inc.

(Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that

John Butler

, Chief Executive Officer, will present virtually at the H.C. Wainwright 24

th

Annual Global Investment Conference. The hybrid conference will take place September 12–14, 2022.

The presentation will be available on-demand beginning

September 12, 2022

through the Investors section of Akebia’s website at

https://ir.akebia.com

for approximately 90 days.


About Akebia Therapeutics


Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in

Cambridge, Massachusetts

. For more information, please visit our website at

www.akebia.com

, which does not form a part of this release.


Akebia Therapeutics Contact



Mercedes Carrasco



[email protected]

Cision
View original content to download multimedia:

https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-virtually-at-the-hc-wainwright-24th-annual-global-investment-conference-301615782.html

SOURCE Akebia Therapeutics

rt Akebia Therapeutics to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

Featured image: Megapixl © Visivasnc

Disclaimer